Patent details

EP4192882 Title: TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB

Basic Information

Publication number:
EP4192882
PCT Application Number:
EP2022060670
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP227247129
PCT Publication Number:
WO2022223771
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB
French Title of Invention:
TRAITEMENT DE LA NÉPHROPATHIE LUPIQUE AVEC ANIFROLUMAB ANTICORPS DU RÉCEPTEUR INF ANTI-TYPE I
German Title of Invention:
BEHANDLUNG VON LUPUS NEPHRITIS MIT ANTI-TYP I INF-REZEPTOR-ANTIKÖRPER ANIFROLUMAB
SPC Number:

Dates

Filing date:
22/04/2022
Grant date:
19/02/2025
EP Publication Date:
14/06/2023
PCT Publication Date:
27/10/2022
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/02/2025
EP B1 Publication Date:
19/02/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/04/2042
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/02/2025
 
 

Name:
Astrazeneca AB
Address:
Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:
SINIBALDI, Dominic
Address:
United States (US)

2

Name:
TUMMALA, Rajendra
Address:
United States (US)

3

Name:
CHIA, Yen Lin
Address:
United States (US)

4

Name:
TRASIEVA, Teodora
Address:
Sweden (SE)

5

Name:
ROSKOS, Lorin
Address:
United States (US)

6

Name:
NEWCOMBE, Paul
Address:
United Kingdom (GB)

7

Name:
ALMQUIST, Joachim
Address:
Sweden (SE)

8

Name:
WHITE, Wendy
Address:
United States (US)

9

Name:
ROUSE, Tomas
Address:
Sweden (SE)

10

Name:
LINDHOLM, Catharina
Address:
Sweden (SE)

11

Name:
RAMASWAMY, Madhu
Address:
United States (US)

Priority

1

Priority Number:
202163178745 P
Priority Date:
23/04/2021
Priority Country:
United States (US)

2

Priority Number:
202163221986 P
Priority Date:
15/07/2021
Priority Country:
United States (US)

3

Priority Number:
202163270091 P
Priority Date:
21/10/2021
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61P 29/00; G01N 33/53; A61M 5/00;

Publication

European Patent Bulletin

1

Issue number:
202508
Publication date:
19/02/2025
Description:
Grant (B1)

2

Issue number:
202513
Publication date:
26/03/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2025
Annual Fee Number:
4
Annual Fee Amount:
41 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages